skip to main content

Voclosporin vs Tacrolimus — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

HardRheumatology PharmacologyVoclosporin vs TacrolimusSCE Rheumatology

At a specialist lupus nephritis clinic, a 38-year-old woman receiving voclosporin with mycophenolate mofetil asks why voclosporin may be operationally simpler to use than tacrolimus. Which statement most accurately identifies this practical advantage while retaining appropriate safety monitoring?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Voclosporin uses standard dosing without routine trough-guided titration, but still requires renal and blood-pressure monitoring

Voclosporin has a sufficiently predictable exposure-response profile to permit standard dosing without routine measurement of trough drug concentrations. This contrasts with systemic tacrolimus, whose variable pharmacokinetics and narrow therapeutic index ordinarily require trough-guided individualisation. This convenience must not be confused with an absence of monitoring: the voclosporin SmPC requires baseline and serial eGFR assessment, blood-pressure monitoring and dose modification for renal deterioration or relevant CYP3A4 interactions. Both drugs inhibit calcineurin, so option E is incorrect, and voclosporin can cause haemodynamic eGFR reduction, hypertension and hyperkalaemia, excluding option B. Option D reverses the monitoring distinction. Option A is incorrect because acquisition cost is not the established practical advantage. AURORA-1 demonstrated efficacy against placebo-based standard therapy, not superiority over tacrolimus.

Reference: Anders HJ et al. Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis. Cells. 2023. https://pubmed.ncbi.nlm.nih.gov/37887284/